A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Recruiting · NCT06628947 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Recruiting | Phase 2 | 2026-06-18 | NCT06628947 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kiora Pharmaceuticals, Inc. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cerulea Clinical Trials | East Melbourne | Australia | 3 |
| Lions Eye Institute | Nedlands | Australia | 2 |
| Queensland Eye Institute | Woolloongabba | Australia | 2 |
| Royal Adelaide Hospital | Adelaide | Australia | 132 |
| Save Sight Institute | Sydney | Australia | 2 |